Newsletter subscription

Do you want to receive our weekly CMN Newsletters by email?

Click here for your free subscription!

Last month CMN Newsletters you will find here.

Some of the best links we picked up around the internet

Intellia Therapeutics has reported positive three-year follow-data from the ongoing Phase 1/2 trial...

Eli Lilly announced today that it will acquire Verve Therapeutics for up to $1.3 billion to develop...

Chinese researchers have developed a thermosensitive, polyamine-modified hydrogel that significantly...

Some of the best links we picked up around the internet

SNIPR Biome has dosed the first patient in its Phase 1b trial of SNIPR001, a CRISPR-CAS-armed...

A new computational framework called CCLMoff uses deep learning and RNA language models to predict...

Modalis Therapeutics has partnered with SOLVE FSHD to advance the development of an experimental...